No abstract

Diiron μ-aminocarbyne compounds, 1a-e, are prepared in two steps from Fe 2 Cp 2 (CO) 4 , negating the need for difficult purification procedures of intermediate species; they are efficiently isolated by alumina chromatography. Minor amounts of μ-aminocarbyne aryl isocyanide compounds, 2a-c, are obtained as side products. The structures of the cations in 1a,c,e are calculated using DFT; the carbyne carbon is generally predicted to be the thermodynamic site of hydride addition, in agreement with a previous experimental finding concerning 1a. Accordingly, the reaction of 1e with NaBH 4 affords a bridging aminocarbene complex, 4, in 85 % yield. Otherwise, the reaction of 1c with NaBH 4 yields the aminocarbyne-cyclopentadiene derivative 3 (70 %), presumably as a consequence of the [a] Scheme 1. Regioselective additions of nucleophiles to the diiron aminocarbyne complex 1a. Results and DiscussionThe commercial compound [Fe 2 Cp 2 (CO) 4 ] was reacted with the appropriate isocyanide, in a ca. 3:2 molar ratio, in acetonitrile solution. [16] The reactions with alkyl isocyanides were conducted under reflux conditions, whereas the reactions with aryl isocyanides proceeded at room temperature. The resulting mixtures were dried under vacuum and the residues were dissolved in dichloromethane and then treated with methyl triflate, thus affording the μ-aminocarbyne complexes 1a-e (Scheme 2). The difficult isolation of the monoisocyanide intermediates (see the Introduction) was unnecessary. The final products 1a-e were efficiently purified by alumina chromatography and were then isolated as microcrystalline, air-stable compounds in 65-92 % yields. The synthesis of 1c-e was accompanied by the side formation of minor products derived from di-isocyanide species, 2a-c. Compounds 2a-c were recovered by the chromatography in 3-12 % yields, although 2a was formerly reported as being Scheme 2. Synthesis of diiron μ-aminocarbyne complexes.Eur. J. Inorg. Chem. 2018, 960-971 www.eurjic.org

Although ferrocene derivatives have attracted considerable attention as possible anticancer agents, the medicinal potential of diiron complexes has remained largely unexplored. Herein, we describe the straightforward multigram‐scale synthesis and the antiproliferative activity of a series of diiron cyclopentadienyl complexes containing bridging vinyliminium ligands. IC50 values in the low‐to‐mid micromolar range were determined against cisplatin sensitive and resistant human ovarian carcinoma (A2780 and A2780cisR) cell lines. Notable selectivity towards the cancerous cells lines compared to the non‐tumoral human embryonic kidney (HEK‐293) cell line was observed for selected compounds. The activity seems to be multimodal, involving reactive oxygen species (ROS) generation and, in some cases, a fragmentation process to afford monoiron derivatives. The large structural variability, amphiphilic character and good stability in aqueous media of the diiron vinyliminium complexes provide favorable properties compared to other widely studied classes of iron‐based anticancer candidates.

Recently, the research activity in the field of the stereospecific polymerization of conjugated dienes has focused on the use of catalysts based on organometallic complexes having a well-defined structure and containing ligands of various types (e.g., phosphines, bis-imines, and pyridylimines), since it has been observed that the nature of the ligand, as expected on the basis of the diene polymerization mechanism proposed several years ago by Porri, is able to exert a strong influence on the polymerization regioand stereoselectivity, on the polymer molecular weights and their distribution, and in some cases to impart a living feature to the catalysts themselves. In this Perspective we highlight the most recent results obtained in this field and discuss possible future developments in this area.

The molecular structure of 1,10-phenanthroline-5,6-dione has been determined by X-ray diffraction analysis. The compound reacts with the tetrachlorides of Group 4 metals affording adducts of general formula [MCl 4 (C 12 H 6 N 2 O 2 )] (M = Ti, Zr or Hf) and [(MCl 4 ) 2 (C 12 H 6 N 2 O 2 )] (M = Ti or Hf), N,NЈ-and N,NЈ,O,OЈ-co-ordinated respectively. The compound [HfCl 4 (C 12 H 6 N 2 O 2 )] is reactive towards TiCl 4 affording the bimetallic compound [Cl 4 Hf(C 12 H 6 N 2 O 2 )-TiCl 4 ]. The reaction of the dione with bis-cyclopentadienyl derivatives of titanium(), zirconium(), [MCp 2 (CO) 2 ], and vanadium(), VCp 2 , affords derivatives O,OЈ-co-ordinated to the MCp 2 moiety. By reaction of [TiCp 2 -(C 12 H 6 N 2 O 2 )] with [TiCp 2 (CO) 2 ] the bimetallic derivative [(TiCp 2 ) 2 (C 12 H 6 N 2 O 2 )] is obtained, which is suggested to contain two TiCp 2 fragments, O,OЈ-and N,NЈ-co-ordinated to 1,10-phenanthroline-5,6-dione. The [MCp 2 -(C 12 H 6 N 2 O 2 )] (M = Ti, Zr or V) derivatives react with MЈCl 4 (MЈ = Ti or Hf) to give [Cp 2 M(C 12 H 6 N 2 O 2 )MЈCl 4 ] bimetallics.

α-Diimines are among the most robust and versatile ligands available in synthetic coordination chemistry, possessing finely tunable steric and electronic properties. A series of novel cationic ruthenium(II) p-cymene complexes bearing simple α-diimine ligands, [(η- p-cymene)RuCl{κ N-(HCNR)}]NO (R = Cy, [1]NO; R = 4-CHOH, [2]NO; R = 4-CHOH, [3]NO), were prepared in near-quantitative yields as their nitrate salts. [2]NO displays high water solubility. The potential of the α-diimine ligand in [3]NO as a carrier of bioactive molecules was investigated via esterification reactions with the hydroxyl groups. Thus, the double-functionalized derivatives [(η- p-cymene)RuCl{κ N-(HCN(4-CHOCO-R))}]NO (R = aspirinate, [5]NO; valproate, [6]NO) and also [4]Cl (R = Me) were obtained in good-to-high yields. UV-vis and multinuclear NMR spectroscopy and cyclic voltammetric studies in aqueous solution revealed only minor ruthenium chloride hydrolytic cleavage, biologically accessible reduction potentials, and pH-dependent behavior of [3]NO. Density functional theory analysis was performed in order to compare the Ru-Cl bond strength in [1] with the analogous ethylenediamine complex, showing that the higher stability observed in the former is related to the electron-withdrawing properties of the α-diimine ligand. In vitro cytotoxicity studies were performed against tumorigenic (A2780 and A2780cisR) and nontumorigenic (HEK-293) cell lines, with the complexes bearing simple α-diimine ligands ranging from inactive to IC values in the low micromolar range. The complexes functionalized with bioactive components, i.e., [5]NO and [6]NO, exhibited a marked increase in the cytotoxicity with respect to the precursor [3]NO.

A straightforward two‐step procedure via single CO removal allows the conversion of commercial [Fe2Cp2(CO)4] into a range of amphiphilic and robust ionic complexes based on a hybrid aminocarbyne/iminium ligand, [Fe2Cp2(CO)3{CN(R)(R’)}]X (R, R’=alkyl or aryl; X=CF3SO3 or BF4), on up to multigram scales. Their physicochemical properties can be modulated by an appropriate choice of N‐substituents and counteranion. Tested against a panel of human cancer cell lines, the complexes were shown to possess promising antiproliferative activity and to circumvent multidrug resistance. Interestingly, most derivatives also retained a significant cytotoxic activity against human cancer 3D cell cultures. Among them, the complex with R=4‐C6H4OMe and R’=Me emerged as the best performer of the series, being on average about six times more active against cancer cells than a noncancerous cell line, and displayed IC50 values comparable to those of cisplatin in 3D cell cultures. Mechanistic studies revealed the ability of the complexes to release carbon monoxide and to act as oxidative stress inducers in cancer cells.

A series of diiron complexes based on the [Fe2Cp2(CO) x ] skeleton (Cp = η5-C5H5, x = 2, 3; η4-C5H5Ph in place of one Cp in one case) and containing different bridging hydrocarbyl ligands (aminocarbyne, thiocarbyne, allenyl) were preliminarily investigated for their anticancer potential. The water solubility, stability in water and in the presence of a cell culture medium, and octanol/water partition coefficient were evaluated by spectroscopic techniques. The cytotoxicity was assessed in vitro toward the human ovarian carcinoma cell line A2780, the human triple negative breast cancer cell line MDA-MB-231, and the human vascular smooth muscle cell line SMC. Some aminocarbyne complexes exhibited a potent cytotoxicity, with IC50 values in the low micromolar/nanomolar range, and a strong selectivity for the A2780 cells in comparison to the SMC cell line. Several experiments were carried out in order to give insight into the mode of action of selected compounds, including an assessment of catalytic NADH oxidation and ROS production and studies of binding with DNA and with a model protein.